tirzepatide glp-1 Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Tirzepatide | DirectMeds

Two recently developed methods for visually presenting complex weight and health-risk information that encapsulate substantial amounts of clinical trial observations were recently developed that can potentially supplement and give new insights into conventional GLP-1R agonist scientific reports

Neurodegenerative diseases, including Alzheimers Disease (AD) and Parkinsons Disease (PD) are common complications of diabetes, arising from insulin resistance, inflammation, and other pathological processes in the central nervous system

Janet Klein, MS RDN, CDN, CDCES, Bariatric Surgery and Obesity Medicine Program Director

As I prepare to publish my Year-End/New Year TrendCast for 2026, I felt like front-ending next weeks annual long post with details on the demand side of the forecast a focus on the consumer, patient, caregiver, health citizen

This isn't another dietit's a metabolic reset system that combines proven supplements with practical guidance